Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Jilin Province (20230402003GH)
National Natural Science Foundation of China (82172230)
Life Spring AKY Pharmaceuticals (3R219F033430)
Changchun Science and Technology Bureau (21ZGY29)
Chunlei project of China-Japan Union Hospital of Jilin University (2023CL07)
- License Information
-
More Information
Article History
Received: 20 October 2023
Accepted: 27 February 2024
First Online: 22 March 2024
Declarations
:
: The ethical approved projects entitled “Study on the aging mechanism of mesenchymal stem cells” was approved by the Medical Ethics Committee of China-Japan Union Hospital of Jilin University. Approval number: 2022-NSFC-052. Date of approval: March 4, 2022. The studies described adhere to the Helsinki declaration.
: Not applicable.
: The authors declare no competing interests.
: <sup>1</sup> Scientific Research Center, China-Japan Union Hospital of Jilin University, Changchun 130000, Jilin, China.<sup>2</sup> Life Spring AKY Pharmaceuticals, Changchun 130000, Jilin, China.<sup>3</sup> Institute of Antler Science and Product Technology, Changchun Sci-Tech University, Changchun 130000, Jilin, China.
